Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

1.

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.

Mattarollo SR, West AC, Steegh K, Duret H, Paget C, Martin B, Matthews GM, Shortt J, Chesi M, Bergsagel PL, Bots M, Zuber J, Lowe SW, Johnstone RW, Smyth MJ.

Blood. 2012 Oct 11;120(15):3019-29. doi: 10.1182/blood-2012-04-426643. Epub 2012 Aug 28.

PMID:
22932803
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.

Mattarollo SR, Steegh K, Li M, Duret H, Foong Ngiow S, Smyth MJ.

Immunol Cell Biol. 2013 Jan;91(1):105-14. doi: 10.1038/icb.2012.58. Epub 2012 Oct 23.

PMID:
23090488
[PubMed - indexed for MEDLINE]
3.

Interleukin-2 gene transfer potentiates the alpha-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma.

Nishihori Y, Kato K, Tanaka M, Okamoto T, Hagiwara S, Araki N, Kogawa K, Kuribayashi K, Nakamura K, Niitsu Y.

Cancer Biol Ther. 2009 Sep;8(18):1763-70.

PMID:
19901518
[PubMed - indexed for MEDLINE]
Free Article
4.

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T.

J Exp Med. 1999 Apr 5;189(7):1121-8.

PMID:
10190903
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.

Chung Y, Qin H, Kang CY, Kim S, Kwak LW, Dong C.

Blood. 2007 Sep 15;110(6):2013-9. Epub 2007 Jun 20.

PMID:
17581919
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.

Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI.

Blood. 2002 Feb 15;99(4):1259-66.

PMID:
11830474
[PubMed - indexed for MEDLINE]
Free Article
7.

Role of γδ T cells in α-galactosylceramide-mediated immunity.

Paget C, Chow MT, Duret H, Mattarollo SR, Smyth MJ.

J Immunol. 2012 Apr 15;188(8):3928-39. doi: 10.4049/jimmunol.1103582. Epub 2012 Mar 12.

PMID:
22412194
[PubMed - indexed for MEDLINE]
Free Article
8.

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.

Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S.

J Immunol. 2001 Jun 1;166(11):6578-84.

PMID:
11359810
[PubMed - indexed for MEDLINE]
Free Article
9.

alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors.

Choi YS, Hoory T, Monie A, Wu A, Connolly D, Hung CF.

Vaccine. 2008 Oct 29;26(46):5855-63. doi: 10.1016/j.vaccine.2008.08.027. Epub 2008 Sep 2.

PMID:
18771701
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.

Wang XF, Lei Y, Chen M, Chen CB, Ren H, Shi TD.

J Viral Hepat. 2013 Apr;20 Suppl 1:27-39. doi: 10.1111/jvh.12061.

PMID:
23458522
[PubMed - indexed for MEDLINE]
11.

DC therapy induces long-term NK reactivity to tumors via host DC.

Shimizu K, Fujii S.

Eur J Immunol. 2009 Feb;39(2):457-68. doi: 10.1002/eji.200838794.

PMID:
19180466
[PubMed - indexed for MEDLINE]
12.

Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.

Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, Motoki K, Kuranaga N, Fukasawa M, Shinomiya N, Seki S.

J Immunol. 2002 Dec 1;169(11):6127-32.

PMID:
12444115
[PubMed - indexed for MEDLINE]
Free Article
13.

Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.

Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, Azuma M, Takeda K, Akira S, Saito A.

Infect Immun. 2001 Nov;69(11):6643-50.

PMID:
11598033
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.

Togashi Y, Chamoto K, Wakita D, Tsutsumi N, Iwakura Y, Matsubara N, Kitamura H, Nishimura T.

Cancer Sci. 2007 May;98(5):721-5. Epub 2007 Mar 14.

PMID:
17359285
[PubMed - indexed for MEDLINE]
15.

α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.

Huang JR, Tsai YC, Chang YJ, Wu JC, Hung JT, Lin KH, Wong CH, Yu AL.

J Immunol. 2014 Feb 15;192(4):1972-81. doi: 10.4049/jimmunol.1302623. Epub 2014 Jan 24.

PMID:
24465013
[PubMed - indexed for MEDLINE]
16.

Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung.

Courtney AN, Thapa P, Singh S, Wishahy AM, Zhou D, Sastry J.

Eur J Immunol. 2011 Nov;41(11):3312-22. doi: 10.1002/eji.201041359. Epub 2011 Sep 19.

PMID:
21818755
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.

Tomura M, Yu WG, Ahn HJ, Yamashita M, Yang YF, Ono S, Hamaoka T, Kawano T, Taniguchi M, Koezuka Y, Fujiwara H.

J Immunol. 1999 Jul 1;163(1):93-101.

PMID:
10384104
[PubMed - indexed for MEDLINE]
Free Article
18.

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.

Fujii S, Shimizu K, Hemmi H, Steinman RM.

Immunol Rev. 2007 Dec;220:183-98. Review.

PMID:
17979847
[PubMed - indexed for MEDLINE]
19.

Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.

Asada H, Kishida T, Hirai H, Satoh E, Ohashi S, Takeuchi M, Kubo T, Kita M, Iwakura Y, Imanishi J, Mazda O.

Mol Ther. 2002 May;5(5 Pt 1):609-16.

PMID:
11991752
[PubMed - indexed for MEDLINE]
Free Article
20.

Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation.

Trobonjaca Z, Kröger A, Stober D, Leithäuser F, Möller P, Hauser H, Schirmbeck R, Reimann J.

J Immunol. 2002 Apr 15;168(8):3763-70.

PMID:
11937527
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk